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Abstract
Exercise is recommended in patients with cardiac failure. In the perioperative patient, exercise is also gaining
popularity as a form of prehabilitation. In this meta-analysis, we examine if exercise is able to reduce natriuretic
peptide levels. Natriuretic peptide (NP) has strong prognostic ability in identifying patients who will develop
adverse postoperative cardiovascular outcomes. The protocol was registered with PROSPERO (CRD42017051468).
The database search included MEDLINE (PubMed), CINAHL (EBSCO host), EMBASE (EBSCO host), ProQuest, Web of
Science, and Cochrane database. The primary outcomes were to determine whether exercise therapy was effective
in reducing NP levels as compared to control group, the shortest time period required to reduce NP levels after
exercise therapy, and whether reducing NP levels decreased morbidity and mortality. Full texts of 16 trials were
retrieved for this review. Exercise therapy showed a significant reduction in natriuretic peptide levels between the
intervention and control groups (SMD − 0.45, 95% CI − 0.88 to − 0.03) with significant heterogeneity between the
included trials. This was also shown in the within a 12-week period.
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Introduction
Historically, exercise was commonly avoided in patients
with heart failure. This has changed dramatically over
the past 30 years with recommendations from inter-
national organisations such as the European Society of
Cardiology and American College of Cardiology Founda-
tion/American Heart Association for the use of exercise
training to improve exercise tolerance and reduce mor-
bidity and mortality (Cattadori et al. 2018).
Exercise is now considered part of preoperative re-
habilitation, also known as prehabilitation, for patients
presenting for surgery. This is based on the philosophy
that improving functional capacity may improve the pa-
tient’s ability to withstand the surgical stress response
and thereby improve postoperative outcomes. Outcomes
such as hospital length of stay, postoperative pulmonary
complications, and quality of life have been improved
with this approach (Drudi et al. 2019).
There is currently no consensus on the type and dur-
ation of exercise needed to improve outcome in surgical
patients (Vermillion et al. 2018) and non-surgical pa-
tients (Smart and Steele 2010). Furthermore, B-type
natriuretic peptide (BNP) testing has been recommended
to identify patients at high risk of perioperative cardio-
vascular events (Duceppe et al. 2017), yet there remains
limited data on the efficacy of exercise to decrease B-
type natriuretic peptides (Smart and Steele 2010) and
decrease subsequent cardiovascular events.
The objective of this systematic review of clinical trials
was to determine whether in adult, medical patients with
cardiac failure, exercise therapy was able to decrease
natriuretic peptide (NP) levels and whether this was as-
sociated with improved cardiovascular outcomes.
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The protocol was registered with PROSPERO
(CRD42017051468). The Preferred Reporting Items for
Systematic reviews and Meta-Analysis (PRISMA) guide-
lines were adhered to (Moher et al. 2009). This protocol
included a meta-analysis included on the effect of med-
ical therapy on NP levels, which is presented in the ac-
companying paper (Alphonsus et al. 2019).
Eligibility criteria
The inclusion criteria for this systematic review have
been described in the systematic review on natriuretic
peptide-directed medical therapy which included exer-
cise therapy trials.
In this systematic review, we report prospective rando-
mised clinical trials of adult medical patients who were ran-
domised to exercise as part of cardiac rehabilitation, where
the subsequent changes in natriuretic peptide levels are re-
ported. We excluded (i) trials that monitored natriuretic
peptides for prognostic or diagnostic purposes, without a
strategy to lower natriuretic peptide levels; (ii) reviews of
natriuretic peptide or biomarker physiology; and (iii) trials
reporting natriuretic peptides in patients with acute myo-
cardial infarction, pulmonary hypertension, cardiac resyn-
chronisation therapy, and left ventricular assist devices.
Information sources, search, and study selection
Three searches were conducted using search terms ‘brain
natriuretic peptide’ AND ‘treatment’, ‘brain natriuretic
peptide’ AND ‘heart failure’, and ‘brain natriuretic peptide’
AND ‘exercise’. The following databases were accessed:
MEDLINE (PubMed), CINAHL (EBSCO host), EMBASE
(EBSCO host), ProQuest, Web of Science, and Cochrane
database. There were no filters used for year of publication
or language. Non-English titles were not excluded. An ex-
ample of the search is shown in Additional file 1. The ini-
tial search was conducted on 22 December 2016 and
updated on 4 March 2018.
Data collection process
Titles were screened for potential inclusion by CA and
PG. Abstracts of potential papers identified through the
title search were then screened using inclusion and ex-
clusion criteria by CA and PG. The full texts of poten-
tial trials were then extracted for full text review and
analysis. Reference lists were searched for additional
papers that could be included in this review. Data ex-
traction was done by one author (CA) and then
checked by a co-author (BB). When required data was
not presented in the publication, the authors were con-
tacted for these data.
Data items
We extracted data on the NP reduction at the end of the
exercise trials. Data on the patient characteristics, the
type of exercise intervention, the physical activity in the
control group, and the mortality and morbidity in the
trials was also extracted.
Outcomes
The primary outcomes for this review were to determine
(i) whether exercise therapy was effective in reducing NP
levels as compared to control group, (ii) the shortest
time period required to reduce NP levels after exercise
therapy, and (iii) whether reducing NP levels decreased
morbidity and mortality. The secondary outcome was to
determine which specific exercise regimens were more
effective in reducing NP levels.
Risk of bias in individual studies
Assessment of bias in the studies was conducted by CA
and verified by BB following discussion. The Cochrane
Collaboration risk of bias tool was used and assessed se-
lection bias, concealment bias, performance bias, detec-
tion bias, attrition bias, and other biases. Studies were
assessed as having low, unclear, or high risk of bias.
Summary measures and synthesis of results
Statistical analyses were conducted using Review Manager
Version 5.3 (Copenhagen: The Nordic Cochrane Centre,
The Cochrane Collaboration, 2014). For NP reduction, we
tabulated the absolute NP change. NP levels which were
reported as median and interquartile range (IQR) were
converted to mean and SD (Wan et al. 2014). As the in-
cluded trials used either BNP or NT-proBNP to monitor
therapeutic response, we made use of standardised mean
difference (SMD) for our meta-analysis. SMD addresses
the difference in the effect size for an intervention when
the units of measurement differ between trials, e.g. use of
BNP or NT-proBNP. The SMD is the difference between
groups in mean end point divided by the SD of the control
group (or pooled SD of the treatment and control groups)
(Guyatt et al. 2015). These data are presented as a forest
plot. Random effects models were used where the I2 statis-
tic > 25% (representing significant heterogeneity); other-
wise, a fixed effects model was used.
Risk of bias across studies
Risk of publication bias across studies was assessed with
funnel plots for NP reduction.
Results
Study selection
After the initial search, 64 articles were reviewed for po-
tential inclusion. Twenty-six trials (27 publications) were
selected and 8 trials added from references, of which 18
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were trials of medical therapy interventions and 16 trials
were of an exercise intervention (Fig. 1).
We evaluated 2 previous systematic reviews using the
AMSTAR format (Additional file 2).
Study characteristics of included studies
Cardiac rehabilitation exercise trials were conducted in
adult patients 18 years and older, in an outpatient setting
(Table 1). The included cardiac rehabilitation exercise tri-
als all included some form of aerobic exercise, either walk-
ing, bicycle, or treadmill. Trials that involved interval
training were considered as a separate subgroup for ana-
lysis (Aksoy et al. 2015; Nilsson et al. 2010; Stevens et al.
2015). Three trials included resistance training in addition
to aerobic training in the intervention group (Gary et al.
2011; Jonsdottir et al. 2006; Malfatto et al. 2009; Norman
et al. 2012). Most trials ran for up to 12 weeks, one trial
for 20 weeks (Jonsdottir et al. 2006), and another for 24
weeks (Norman et al. 2012). Most trials were small, with a
maximum of 40 patients in each arm, with the exception
of 1 large trial (HF-ACTION) which included 477 patients
(Ahmad et al. 2014). Most trials included patients with an
ejection fraction (EF) < 40%, two trials had patients with
EF 40–49% (Guazzi et al. 2012; Parrinello et al. 2010), and
three trials had patients with mixed categories of heart
failure (Aksoy et al. 2015; Jonsdottir et al. 2006; Nilsson
et al. 2010). The exercise intervention protocols were not
individualised to the NP levels, but the NP response to the
exercise intervention was reported in all the trials.
The exercise intervention group received supervised
exercise training in all the trials, except two where the
exercises were home-based after participants were given
instructions (Eleuteri et al. 2013; Parrinello et al. 2010).
The control group were given exercise information
Fig. 1 PRISMA flow diagram
Alphonsus et al. Perioperative Medicine            (2019) 8:14 Page 3 of 8
(except Brubaker (Brubaker et al. 2009)) but did not re-
ceive supervised exercise training.
Risk of bias within studies and across studies
The risk of bias of the included trials is shown in the
Additional file 3: Figure S1 and Additional file 4: Figure
S2. The random sequence generation was acceptable in
three trials (Ahmad et al. 2014; Guazzi et al. 2012; Maria
Sarullo et al. 2006). By virtue of the intervention (super-
vised exercise versus exercise recommendation), blinding
of patients was impossible, and investigator blinding was
poor. Outcome assessors were only blinded in two trials
(Ahmad et al. 2014; Brubaker et al. 2009). The funnel
plots for SMD (Fig. 2) did not suggest publication bias.
Results of individual studies and synthesis of results
All trials presented data on NP levels at the end of the
intervention period.
Is exercise therapy as effective in reducing NP levels as
compared to control group?
The meta-analysis of the SMD in NP levels between the
intervention and control group is shown in Fig. 3. The
overall point estimate showed a significant reduction in
NP levels between the intervention and control groups
(SMD − 0.45, 95% CI − 0.88 to − 0.03) with significant
heterogeneity between the included trials. Neither the
continuous aerobic, nor the interval training subgroup
showed a significant reduction in NP.
What is the shortest time period required to reduce NP
levels after exercise therapy?
An analysis of the trials with a 12-week intervention
period (the shortest exercise intervention period in the
eligible trials) showed a significant NP reduction (SMD
− 0.75, 95% CI − 1.17 to − 0.33) (Fig. 4).
Does reducing NP levels decreased morbidity and mortality?
Only four trials reported on mortality (Ahmad et al.
2014; Brubaker et al. 2009; Jonsdottir et al. 2006; Nils-
son et al. 2010). HF-ACTION trial (Ahmad et al. 2014)
reported 189 (16%) deaths in the intervention group
and 198 (17%) deaths in the control group, HR 0.96
(0.79–1.17), p = 0.70, and a cardiovascular mortality at a
median follow-up of 30 months of 131 (11%) deaths in
the intervention group and 143 (12%) deaths in the
control group, 0.92 (0.74–1.15), p = 0.47. Three other
trials, Nilsson et al. (2010), Jónsdóttir et al. (2006), and
Brubaker et al. (2009), reported mortality. Nilsson et al.
reported one death in the control group, Jónsdóttir
et al. two each in intervention and control groups, and
Brubaker et al. one in each group. None of other trials
reported mortality.
Table 1 Trial characteristics of cardiac rehabilitation exercise trials





Kobayashi et al. 2003 Stable NYHA II-III. EF < 40% BNP 281 ± 92
Meyer et al. 2004 Stable NYHAII-III. EF≤ 40% NT-proBNP 1092 ± 980
Jonsdottir et al. 2006 Patients previously hospitalised in past 3 years for heart failure BNP 173.2 ± 180.4
Maria Sarullo et al. 2006 Stable CHF. EF < 40% NT-proBNP 3376 pg/ml ± 3133
Brubaker et al. 2009 CHF. EF≤ 45% BNP 176 ± 38
Malfatto et al. 2009 Chronic heart failure BNP 293 ± 115
Parrinello et al. 2010 Stable NYHAII-III. EF≤ 45% BNP 205.2 ± 46.5
Gary et al. 2011 Stable NYHA II-III, stable on medical therapy. EF 15 to 40% BNP 184.4_151.6
Guazzi et al. 2012 Stable NYHA class II or III, stable on medical therapy. EF≤ 45% NT-proBNP 1088.1 ± 447.1
Norman et al. 2012 Volunteers, NYHAII-IV, ≥ 21 years, LVEF≤ 40%, on optimal medical
therapy
BNP 1088.1 ± 447.1
Sandri et al. 2012 Stable CHF. EF < 40% NT-proBNP ≤ 55 years, 1675 ± 354
≥ 65 years, 1301 ± 261
Eleuteri et al. 2013 Stable NYHA II, stable on medical therapy. EF≤ 40% NT-proBNP 1570.7 ± 3125.8
Ahmad et al. 2014, HF-ACTION
substudy
CHF patients with reduced left ventricular ejection fraction (< 35%) NT-proBNP 960.6 ± 1114
Aksoy et al. 2015 NYHAII-III CHF on optimal medical therapy. EF 35 to 55% NT-proBNP Continuous aerobic
exercise group 20.79 ± 12.8
Interval exercise group
24.00 ± 18.27
NP natriuretic peptide, CHF chronic heart failure, EF left ventricular ejection fraction, BNP B-type natriuretic peptide, NT-proBNP N-terminal pro-B-type natriuretic
peptide, NYHA New York Heart Association
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Fig. 2 Funnel plot for standardised mean difference forest plot. SMD- standardised mean difference
Fig. 3 Standardised mean difference in natriuretic peptide levels in exercise therapy. SD-standard deviation; CI-confidence interval
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Secondary outcome: where specific exercise regimens were
more effective in reducing NP levels?
Neither supervised continuous aerobic exercise or interval
training was independently associated with a significant re-
duction in NP levels. A preferable exercise regimen therefore
cannot be determined.
Discussion
This meta-analysis examines exercise rehabilitation in
adult patients with chronic heart failure in an outpatient
setting. The principal finding was that exercise training
can significantly decrease NP levels within 12 weeks in
adult medical patients eligible for cardiac rehabilitation.
The patients most likely to benefit from this intervention
had stable chronic heart failure, with an EF which was
predominantly < 45% (Table 1). However, significant
heterogeneity exists between trials. Currently, there is in-
sufficient data to determine whether this NP reduction
is also associated with a survival benefit.
The characteristics of the exercise programmes were the
following (Table 2). Almost all trials included exercise
programmes that were conducted under direct supervi-
sion. All the programmes had an aerobic component and
varied in exercise intensity, duration, and frequency. Few
trials had interval training and resistance training. The ex-
ercise regimens were predominantly determined by
patient-specific physiological parameters, e.g. AT, VT, and
VO2 peak, and were thus individualised. The duration of
the exercise programme was 12 weeks in most trials.
These findings are applicable to patients with cardiac fail-
ure of varying severity but considered stable on medica-
tion. It is important to note that NP levels were not a
criterion for inclusion in these trials, and hence, we do not
know the baseline NP level necessary to determine eligi-
bility for a supervised exercise programme.
The strength of this meta-analysis is that it shows ex-
ercise training to be associated with a reduction in NP
levels within 12 weeks from randomisation. There were
no reports of morbidity associated with the supervised
exercise programmes.
This review has some limitations. Firstly, the protocols
differed between trials making it difficult to recommend a
specific exercise programme. This may partly explain the
significant heterogeneity in the included studies. However,
despite the significant heterogeneity, the random effects
meta-analysis suggests that the reduction in NP levels as-
sociated with exercise training is possible within 12 weeks.
There remains limited mortality data in the trials of car-
diac rehabilitation programmes which document NP level
changes over time. It is thus impossible to determine
whether a reduction in NP levels secondary to exercise
therapy is associated with increased survival. It is possible
that an exercise intervention may improve other patient
reported outcomes, although these were not uniformly re-
ported in the included trials. Finally, as all of the trials
were not blinded to the patient or investigator, it is pos-
sible that there may be co-intervention bias associated
with the exercise arm of these trials.
Our review differs from the two previous systematic
reviews which have examined NP levels in non-surgical
patients after exercise therapy (Pearson et al. 2018;
Smart and Steele 2010). These reviews also found that
NP levels were reduced after exercise therapy, with a
high heterogeneity in the response. The strength of our
review is that it updates the previous reviews (Smart and
Steele 2010) with more trials and only includes RCTs
with aerobic exercise programmes (Pearson et al. 2018).
We did not consider trials examining yoga, stretching,
Tai chi, functional electrical stimulation, or inspiratory
muscle training (Pearson et al. 2018).
Fig. 4 Standardised mean difference in natriuretic peptide levels in exercise therapy within 12 weeks. SD-standard deviation; CI-confidence
interval
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Elevated preoperative NP levels have been independ-
ently associated with major adverse cardiac events and
mortality following surgery (Rodseth et al. 2008, 2011,
2014). Further investigation into the role of supervised
preoperative exercise programme in the surgical popula-
tion may provide insight into the relationship between
exercise and NP levels in this cohort of patients.
Conclusion
This meta-analysis shows that NP levels can be lowered
with supervised exercise training and can be achieved
within a 12-week programme. An exercise prehabilitation
programme of 12 weeks duration may lower NP levels,
and possibly perioperative risk. It is unclear whether this
will improve postoperative cardiovascular outcomes.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13741-019-0124-0.
Additional file 1: Example of search strategy for the systematic review.
Additional file 2: AMSTAR evaluation of previous systematic reviews.
Additional file 3: Figure S1. Risk of bias graph.
Additional file 4: Figure S2. Risk of bias summary.
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Table 2 Characteristics of exercise programme in the intervention group








Meyer et al. 2004 Cycle at for 45 min. 4 times/week 12
weeks
Not specified
Jonsdottir et al. 2006 Aerobic and resistance training. Cycle for 15 min, 50% of peak work load, and gradually















Malfatto et al. 2009 Cycle or treadmill 40 min HR to 60% of VO2 peak. 3 times/week 12
weeks
No training










Guazzi et al. 2012 Cycle ergometer 40 min. 60% HRR 12
weeks
Not specified
Norman et al. 2012 Aerobic exercise, 3 days a week, at 40%–70% heart rate reserve, based on the baseline CPET,
or 11–14 on Borg scale for 30 min with 15 min warm-up and 15min cool-down. Resistance
training, 2 days a week, 8–10 exercises (upper and lower body) performed for one set of 10






Sandri et al. 2012) Cycle 4 times/day. Workloads were adjusted to heart rate so that 70% of the symptom-










Ahmad et al. 2014, HF-
ACTION substudy
Supervised 3 times per week: walking/treadmill/stationary cycling. Initial 15 to 30 min heart






Aksoy et al. 2015 Supervised two groups, continuous up to 50% VO2 peak no change in intensity. Interval




VO2 maximum oxygen consumption, HR heart rate, HRR heart rate reserve, AT aerobic training, CPET cardiopulmonary exercise training, VT ventilatory threshold
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